EverCommerce Inc. (EVCM) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary shows strong financial performance with a 6.4% revenue growth, high gross margins, and effective cost management. The Q&A reveals strong uptake of AI initiatives and confidence in future growth, despite some unclear responses on monetization specifics. The company maintains a healthy financial position with strategic investments in AI and customer engagement, supporting a positive outlook. Given the company's market cap, the stock price is likely to react positively, within the 2% to 8% range, over the next two weeks.
Key Financial Performance
Revenue (Q4 2025) $151.2 million, representing a 5.2% year-over-year growth. The growth was attributed to meeting or exceeding financial targets and operational improvements.
Adjusted EBITDA (Q4 2025) $44.2 million, representing a 29.2% margin. This was flat year-over-year, reflecting operational discipline and efficiency improvements.
Pro Forma Revenue (LTM) $591.7 million, representing a 6.4% year-over-year growth. The increase was due to the acquisition of ZyraTalk and operational improvements.
Adjusted Gross Profit (Q4 2025) $117 million, representing an adjusted gross margin of 77.5%. This reflects operational efficiency.
Net Revenue Retention (NRR) 96%, with multi-solution customers generating NRR above 100%. This was driven by cross-sell metrics and customer success initiatives.
Top 6 Solutions TPV Growth 17.4% year-over-year, now representing 36% of total TPV. This growth was due to focused investments in these solutions.
Top Solution Payment Revenue Growth 5.9% year-over-year, now representing over 45% of total payment revenue. This was driven by investments in growth solutions.
Cash Flow from Operations (2025) $111.5 million, compared to $113.2 million in 2024. The slight decrease was due to the sale of the Marketing Technology Solutions business.
Levered Free Cash Flow (2025) $79.6 million, compared to $94.3 million in 2024. The reduction was due to increased capitalized software costs related to strategic investments in product.
Adjusted Unlevered Free Cash Flow (2025) $130.5 million, compared to $134.5 million in 2024. The decrease was due to increased transaction-related and nonrecurring costs and capitalized software investments.
Debt Outstanding (End of 2025) $527 million, with a total net leverage of approximately 2.2x. This reflects strong operational performance and free cash generation.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
AI-driven documentation capabilities: EverHealth introduced AI-driven documentation capabilities that reduce documentation time per visit, surface structured clinical insights, and support better diagnostic decisions. This has resulted in an average documentation time savings of 8 minutes per patient and a 99.1% satisfaction rate.
AI-powered patient scheduling: EverHealth implemented intelligent no-show prediction, automated call routing, and self-service booking tools. These tools have reduced patient no-show rates by 60%, leading to increased revenue capture of around $1,000 per month per provider.
AI-driven revenue cycle management: EverHealth is building intelligent revenue cycle management and billing capabilities, including automated coding support, claim scrubbing, and AI-driven rejection analysis to improve collection rates and accelerate payment cycles.
Integrated patient communication: AI-assisted message triage and smart document analysis have been introduced to allow practices to respond to patients faster and embed workflow recommendations directly into the platform.
Customer base expansion: EverCommerce serves over 745,000 customers across its three verticals: EverPro, EverHealth, and EverWell. The company has seen a 26% year-over-year growth in customers enabled for more than one solution and a 32% year-over-year growth in customers actively utilizing more than one solution.
Payment volume growth: Annualized total payment volume expanded to $13 billion, with the Top 6 Solutions growing TPV by 17.4% year-over-year.
Operational efficiency improvements: Adjusted EBITDA margin expanded to 30.7% on an LTM basis, reflecting operational discipline and efficiency improvements.
AI-first focus: EverCommerce has adopted an AI-first focus, embedding AI capabilities into its platforms to drive efficiency, speed, and cost savings.
Sale of Marketing Technology business: EverCommerce sold its Marketing Technology Solutions business, which had been a detractor to growth and predictability.
Acquisition of ZyraTalk: The acquisition of ZyraTalk has provided a strong foundation for current and future AI product initiatives.
Leadership update: Matt Feierstein, EverCommerce's President, has taken on the additional role of CEO of EverPro to focus on execution and growth.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Sale of Marketing Technology Solutions business: The sale of the Marketing Technology Solutions business, while removing a detractor to growth and predictability, may have short-term impacts on revenue and operational adjustments.
AI-first investments: Significant investments in AI-first products and workflows could strain financial resources and may not yield the expected returns or adoption rates.
Customer no-show rates: Although AI-driven no-show predictors have reduced no-show rates, there is a dependency on the adoption and effectiveness of these tools to maintain revenue capture.
Debt and financial leverage: The company has $527 million of debt outstanding, with a net leverage ratio of 2.2x. While manageable, this level of debt could pose risks if operational performance declines or interest rates rise.
Seasonal cash flow variability: The first quarter is historically burdened by higher cash outflows, which could impact liquidity and operational flexibility.
Dependence on small business customers: The company's customer base consists of small businesses, which are inherently more vulnerable to economic downturns and market volatility.
Revenue concentration in EverPro and EverHealth: Approximately 95% of consolidated revenue comes from EverPro and EverHealth, making the company highly dependent on the performance of these two verticals.
Regulatory and compliance risks in healthcare: The EverHealth vertical operates in the healthcare sector, which is subject to stringent regulatory and compliance requirements that could pose operational and financial risks.
Integration of AI into workflows: While AI integration is a focus, there is a risk that these initiatives may not be seamlessly adopted by customers, potentially impacting customer satisfaction and retention.
Leadership changes: Recent leadership changes, such as the appointment of a new CEO for EverPro, could lead to transitional challenges or shifts in strategic focus.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Guidance for Q1 2026: Expected total revenue of $145.5 million to $148.5 million.
Revenue Guidance for Full Year 2026: Expected total revenue of $612 million to $632 million.
Adjusted EBITDA Guidance for Q1 2026: Expected adjusted EBITDA of $39 million to $41 million.
Adjusted EBITDA Guidance for Full Year 2026: Expected adjusted EBITDA of $183 million to $191 million.
AI Investments and Product Development: Continued investment in AI-based features, payments enablement, and go-to-market organization to drive growth in the latter portion of 2026.
Seasonal Performance Expectations: Typical seasonal performance expected, with stronger growth in the second and third quarters of 2026.
Cash Flow Expectations: Less seasonal variability in cash flow from operations expected due to the sale of the Marketing Technology business, though Q1 remains historically burdened by higher cash outflows.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase Program: In 2025, EverCommerce deployed nearly $85 million of capital to repurchase 8.2 million shares of its common stock. Additionally, during the fourth quarter, the company repurchased 2.5 million shares for $24.8 million at an average price of $9.91 per share. As of December 31, 2025, approximately $47.7 million remains in the total repurchase authorization of $300 million, which extends through the end of 2026.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What has been the customer appetite for ZyraTalk and other agentic functionalities?
A:The management highlighted that ZyraTalk represents the next pivot in their AI strategy, moving from generative to voice AI. Early integrations and sales uptake have been strong, with progress exceeding expectations earlier in the year. They are building a centralized agentic platform to scale agent capabilities, automate workflows, and monetize through premium features, increased pricing, and stronger retention.
Q:What are the assumptions underlying the 2026 growth outlook?
A:The management feels confident about 2026 growth, citing strong revenue performance in 2025 and continued investments in AI. These investments are expected to drive reacceleration in revenue growth throughout 2026, which is reflected in their guidance.
Q:What caused the year-over-year decline in payments revenue from non-Top 6 solutions?
A:The decline is not related to the MarTech divestiture. The portfolio includes a mature segment generating strong cash flow and a growth segment focused on the Top 6 solutions. The Top 6 solutions grew 6% in revenue, driven by a 17% year-over-year growth in TPV, while the non-Top 6 solutions declined.
Q:What are the most important moats for the business as agentic AI adoption accelerates?
A:The management emphasized their advantages, including millions of minutes of data for training AI, deep niche vertical expertise, and a large customer base (100,000+ in EverHealth). They also highlighted their ability to deliver compliant, end-to-end digital solutions in highly regulated industries.
Q:What is the incremental revenue impact of the no-show prediction tool?
A:The no-show prediction tool is currently included in packages and not priced a la carte. However, updated package sets with increased prices are being rolled out, which will raise the overall ASP for new practices purchasing EverHealth solutions.
Q:What explains the Q1 guidance being lower than Q4 revenue?
A:Q1 typically experiences lower seasonality compared to Q4. The company is making deliberate investments in payments and go-to-market strategies, which are expected to drive reacceleration in revenue growth throughout the year. Adjusted EBITDA margins are expected to remain strong, with continued investments in AI platforms.
Q:What is the timing for the AI product roadmap rollout for EverPro and EverHealth?
A:For EverHealth, the Scribe feature will be generally available by the end of Q1, with additional features rolling out throughout the year. For EverPro, some generative components have already been released, and the majority of voice reception systems and the shared agentic platform are expected in H2.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the incremental revenue impact of the no-show prediction tool, as it is currently included in packages and not priced a la carte. Additionally, while they discussed the timing of AI product rollouts, they did not provide precise metrics or timelines for monetization and performance beyond general expectations.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
EverHealth EverPro
EverHealth platform
Finance Head
Marketing Technology
Solutions
ZyraTalk
activation
analysis
automation
book
capital
care provider
change
collection
core solution
customer success
cycle
documentation
driver
efficiency
example AI
expertise
function
gain
goal
health care
moment
patient
payment point
payment solution
product development
receptionist
retention wallet
saving
show
solution AI
structure
tool
work
year
EVCM Transcript
EverCommerce Inc. (EVCM) Q4 2025 Earnings Call Transcript
Positive3-12
The earnings call summary shows strong financial performance with a 6.4% revenue growth, high gross margins, and effective cost management. The Q&A reveals strong uptake of AI initiatives and confidence in future growth, despite some unclear responses on monetization specifics. The company maintains a healthy financial position with strategic investments in AI and customer engagement, supporting a positive outlook. Given the company's market cap, the stock price is likely to react positively, within the 2% to 8% range, over the next two weeks.
EverCommerce Inc. (EVCM) Q3 2025 Earnings Call Transcript
Positive11-7
The earnings call highlights a positive financial performance with revenue and EBITDA growth, cost optimization, and margin expansion. The share repurchase program increase is a positive catalyst. Despite some macroeconomic impacts, guidance remains strong. The Q&A session provided clarity on strategic acquisitions and pricing models, with management showing confidence in future growth. Given the company's market cap, these factors suggest a positive stock price movement of 2% to 8% over the next two weeks.
EverCommerce Inc. (EVCM) Q2 2025 Earnings Call Transcript
Positive8-7
The earnings call summary shows strong financial performance, with stable gross margins and improved cash flows. AI initiatives and payment strategies are promising, and the shareholder return plan is favorable. The Q&A section reveals cautious yet optimistic guidance, with management focusing on efficiency and growth. The market cap suggests a moderate reaction, resulting in a positive stock price movement prediction.
EverCommerce Inc. (EVCM) Q1 2025 Earnings Call Transcript
Positive5-10
The earnings call highlights strong financial performance with a 3.2% revenue increase and 16.3% EBITDA growth. Positive guidance for 2025 and a $50 million share repurchase program further bolster sentiment. Despite competitive pressures and debt concerns, the company's strategic transformation and focus on payments integration provide growth potential. The Q&A session reassures on macroeconomic impacts and emphasizes upsell opportunities, supporting a positive outlook. Given the market cap of approximately $2 billion, the stock price is likely to experience a moderate positive reaction, estimated between 2% to 8%.
EVCM Slides
EVCM Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
